AU:ARX Stock Latest News
Company AnnouncementsAroa Biosurgery Options Lapse Trims Potential Future Dilution2w agoARX
Company AnnouncementsAroa Biosurgery Highlights Symphony Trial and Regenerative Healing Strategy2w agoARX
Company AnnouncementsAroa Biosurgery Outlines Interim MASTRR Study Update and Investor Guidance3w agoARX- Company AnnouncementsAroa Biosurgery to Brief Investors on Interim MASTRR Registry Findings1M agoARX
Company AnnouncementsAroa Biosurgery Study Shows Low Infection Rates for Myriad Bioscaffold1M agoARX
Company AnnouncementsAroa Biosurgery Issues New Unquoted Equity Under Employee Incentive Schemes2M agoARXCompany AnnouncementsAroa Biosurgery Director John Diddams Steps Down but Retains Indirect Stake2M agoARX
Company AnnouncementsAroa Biosurgery shareholders back all resolutions at Annual General Meeting2M agoARX
Company AnnouncementsAroa Biosurgery Issues Investor Education Presentation With Key Disclaimers2M agoARX
Company AnnouncementsAroa Biosurgery Issues New Restricted Stock Units Under Employee Scheme2M agoARX- Company AnnouncementsAroa Biosurgery Issues 2.9 Million Restricted Stock Units Under Employee Incentive Plan3M agoARX
Company AnnouncementsAroa Biosurgery strengthens US commercial leadership to drive global growth3M agoARX
Company AnnouncementsAroa Biosurgery Sets Fully Virtual 2026 AGM with Governance and CEO Incentive Votes3M agoARXCompany AnnouncementsAroa Biosurgery Welcomes CMS Plan to Keep Outpatient Skin Substitute Rates3M agoARX
- Company AnnouncementsAroa Biosurgery CFO James Agnew Resigns After 13 Years of Service3M agoARX
Company AnnouncementsAroa Biosurgery Lodges Appendix 4G, Reaffirming ASX Governance Compliance4M agoARX- Company AnnouncementsAroa Biosurgery Sets Out 2026 Performance and Key Dates in Annual Report4M agoARX
- Company AnnouncementsAroa Biosurgery director trims indirect shareholding in on-market sale4M agoARX
Company AnnouncementsAroa Biosurgery Sets AGM Date as Long-Serving Director Plans Retirement4M agoARXCompany AnnouncementsAroa Biosurgery Lifts FY26 Revenue 23% and Targets Further Growth With Higher FY27 Investment5M agoARX
